Table 1:

Baseline Characteristics of the Women (N=224)

Age, years (mean±SD)	55±11
Race
White, n (%)	181 (81%)
African-American, n (%)	40 (18%)
Others, n (%)	3 (1%)
History of Diabetes, n (%)	49 (22%)
History of Hypertension, n (%)	125 (56%)
Family History Coronary Disease, n (%)	142 (66%)
Dyslipidemia, n (%)	105 (52%)
CAD minimal or none, n (%)	179 (81%)
Current smoking, n (%)	44 (20%)
Coronary Hemodynamics
CFR, mean±SD (N=200)	2.56 0.76
ΔCBF (%) (N=113)	79 ± 107%
ΔCSA (IC-Ach) (%) (N=126)	2.68 ± 24.45%
ΔCSA (IC-NTG) (%) (N=131)	20.13 ± 24.51%
Baseline Medications
ACE-I/ARB	54 (24%)
Beta Blockers	65 (29%)
CCD	58 (26%)
Nitrates	47 (21%)
Statins	38 (17%)
Aspirin	110 (50%)
Vasodilators	15 (7%)

CAD: coronary artery disease, CFR: coronary flow reserve, CBF: coronary blood flow, CSA: coronary cross-sectional area, IC-Ach: intra-coronary acetylcholine infusion, IC-NTG: intra-coronary nitroglycerine, ACE-I: angiotensin converting enzyme inhibitor, ARB: angiotensin receptor blocker, CCB: Calcium channel blockers.